Selecting lymph node-positive patients for adjuvant therapy after radical prostatectomy and extended pelvic lymphadenectomy: An outcome analysis of 100 node-positive patients managed without adjuvant therapy.

Tamhankar, Ashwin Sunil; Patil, Saurabh; Singh, Shanky; Carbin, Danny Darlington; Mokal, Smruti; Ahluwalia, Puneet; Gautam, Gagan

Tamhankar, Ashwin Sunil; Patil, Saurabh; Singh, Shanky; Carbin, Danny Darlington; Mokal, Smruti; Ahluwalia, Puneet; Gautam, Gagan.

Afiliación

Tamhankar AS; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.
Patil S; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.
Singh S; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.
Carbin DD; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.
Mokal S; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.
Ahluwalia P; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.
Gautam G; Urologic Oncology and Robotic Surgery, Max Institute of Cancer Care, New Delhi, India.

Curr Urol ; 16(4): 232-239, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36714232

Palabras clave

Adjuvant therapy; Extended pelvic lymph node dissection; Prostate cancer; Robotic radical prostatectomy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Curr Urol Año: 2022 Tipo del documento: Article País de afiliación: India